These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15389262)

  • 1. Anti-TNF alpha therapy in chronic necrotizing scleritis resistant to standard immunomodulatory therapy in a patient with Wegener's granulomatosis.
    El-Shabrawi Y; Hermann J
    Eye (Lond); 2005 Sep; 19(9):1017-8. PubMed ID: 15389262
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment.
    Kontkanen M; Paimela L; Kaarniranta K
    Acta Ophthalmol; 2010 May; 88(3):e96-7. PubMed ID: 19758399
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis.
    Onal S; Kazokoglu H; Koc A; Yavuz S
    Ocul Immunol Inflamm; 2008; 16(5):230-2. PubMed ID: 19065418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
    Mukhtyar C; Luqmani R
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab as rescue therapy in three cases of paediatric Wegener's granulomatosis.
    Wilkinson NM; Erendzhinova E; Zeft A; Cabral DA
    Rheumatology (Oxford); 2006 Aug; 45(8):1047-8. PubMed ID: 16735453
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.
    Cheung CM; Murray PI; Savage CO
    Br J Ophthalmol; 2005 Nov; 89(11):1542. PubMed ID: 16234479
    [No Abstract]   [Full Text] [Related]  

  • 7. TNF-inhibitors in Wegener's granulomatosis.
    Lamprecht P; Voswinkel J; Gross WL
    Kidney Blood Press Res; 2005; 28(1):62. PubMed ID: 15557770
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab efficiency in refractory Wegener's granulomatosis.
    Rozin A
    Rheumatology (Oxford); 2003 Sep; 42(9):1124-5; author reply 1125-6. PubMed ID: 12923277
    [No Abstract]   [Full Text] [Related]  

  • 9. Recovery from multiple cranial nerve palsy of Wegener's granulomatosis with infliximab.
    Fujikawa K; Kawakami A; Eguchi K
    J Rheumatol; 2008 Jul; 35(7):1471-2. PubMed ID: 18609728
    [No Abstract]   [Full Text] [Related]  

  • 10. [Infliximab in the treatment of Wegener's granulomatosis: case report].
    Svozílková P; Ríhová E; Brichová M; Diblík P; Kuthan P; Poch T
    Cesk Slov Oftalmol; 2006 Jul; 62(4):280-6. PubMed ID: 16895062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleritis--Wegener's granulomatosis.
    Opremcak EM
    Insight; 2012; 37(4):13. PubMed ID: 23256431
    [No Abstract]   [Full Text] [Related]  

  • 13. Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy.
    Ashok D; Ayliffe WH; Kiely PD
    Rheumatology (Oxford); 2005 Jul; 44(7):950-1. PubMed ID: 15827040
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis.
    Jabbarvand M; Fard MA
    Ocul Immunol Inflamm; 2010 Jun; 18(3):216-7. PubMed ID: 20482401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.
    Ragam A; Kolomeyer AM; Fang C; Xu Y; Chu DS
    Ocul Immunol Inflamm; 2014 Dec; 22(6):469-77. PubMed ID: 24354512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of Wegener's granulomatosis and disease relapse.
    Bacon PA
    N Engl J Med; 2005 Jan; 352(4):330-2. PubMed ID: 15673799
    [No Abstract]   [Full Text] [Related]  

  • 17. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis.
    Cazabon S; Over K; Butcher J
    Eye (Lond); 2005 Feb; 19(2):222-4. PubMed ID: 15258602
    [No Abstract]   [Full Text] [Related]  

  • 18. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
    Stone JH; Holbrook JT; Marriott MA; Tibbs AK; Sejismundo LP; Min YI; Specks U; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune WJ; Ytterberg SR; Allen NB; Hoffman GS;
    Arthritis Rheum; 2006 May; 54(5):1608-18. PubMed ID: 16646004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleritis: presentations, disease associations and management.
    Sims J
    Postgrad Med J; 2012 Dec; 88(1046):713-8. PubMed ID: 22977282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases.
    Langford CA
    Nat Clin Pract Rheumatol; 2008 Jul; 4(7):364-70. PubMed ID: 18506159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.